Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
OPERATING ACTIVITIES
Net (loss) income	$ (11,968)	$ 5,598
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	9,295	1,290
Depreciation	1,121	850
Amortization of intangible assets	663	258
Accretion of discounts, net	(204)	(1,947)
Origination of loans to be sold	(4,210)	(9,362)
Proceeds from loan sales	4,537	10,115
Gain on sale of loans	(465)	(753)
Share-based and deferred compensation	1,049	656
Capitalized mortgage servicing rights		(71)
Bank-owned life insurance income	(738)	(497)
Loss (gain) on sale of debt securities, available for sale	2,370	(13)
Change in accrued interest receivable and other assets	(3,800)	(3,605)
Change in accrued interest payable and other liabilities	2,340	(175)
Net cash (used in) provided by operating activities	(10)	2,344
Investment securities available for sale:
Proceeds from sales	91,364	513
Proceeds from calls and maturities		1,245
Proceeds from principal repayments	8,285	11,903
Purchases	(9,756)
Investment securities held to maturity
Proceeds from principal repayments	3,436	2,585
Purchases	(11,289)	(34,389)
Proceeds from redemptions of certificates of deposit with other banks	5,623	7,205
Purchase of restricted investment in bank stocks	(15,624)	(7,996)
Redemption of restricted investment in bank stocks	21,799	7,304
Increase in loans, net	(65,915)	(206,406)
Purchase of bank-owned life insurance	(9,712)
Proceeds from death benefit under bank-owned life insurance		41
Purchase of premises and equipment	(1,153)	(2,304)
Purchase of computer software	(220)	(2,291)
Net cash acquired through merger and acquisition	41,745
Net cash provided by (used in) investing activities	58,583	(222,590)
FINANCING ACTIVITIES
Increase in deposits, net	51,834	175,107
Change in short-term borrowings, net	(65,640)	1,124
Proceeds from issuance of subordinated debt		20,000
Issuance of shares from exercise of stock options	150	120
Dividends paid	(4,870)	(3,334)
Net proceeds from issuance of common stock	10,132	34,650
Net cash (used in) provided by financing activities	(8,394)	227,667
(Decrease) Increase in cash and cash equivalents	50,179	7,421
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	30,011	22,590
CASH AND CASH EQUIVALENTS AT END OF PERIOD	80,190	30,011
SUPPLEMENTAL CASH FLOW DISCLOSURES
Interest	27,874	6,585
Income taxes		$ 395
Non-cash assets acquired:
Securities available for sale	123,440
Loans	1,240,334
Investments in restricted bank stock	6,763
Premises and equipment	15,504
Right-of-Use Asset	6,042
Bank-owned life insurance	19,153
Goodwill	21,126
Intangible Assets	25,344
Deferred tax assets	14,466
Accrued interest receivable and other assets	10,730
Liabilities assumed:
Deposits	1,299,867
Other borrowings	55,292
Subordinated debt	21,078
Operating lease liabilities	6,908
Accrued interest payable and other liabilities	5,724
Net non-cash assets acquired	94,033
Cash and cash equivalents acquired	$ 41,745